Tetanus: all 206 studies
Page 1 of 3. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine AdsorbedRecruitingNCT07891104Phase 1/2
- PHASE 1 TRIAL OF Lm-LLO-TT AND GEMCITABINE IN UNRESECTABLE PANCREATIC DUCTAL ADENOCARCINOMANot yet recruitingNCT07828236Phase 1
- Observation of Immune Persistence in a Clinical Trial of an Adsorbed Tetanus VaccineNot yet recruitingNCT07807033
- Study of BK1803 in Healthy InfantsNot yet recruitingNCT07793513Phase 3
- A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined VaccineNot yet recruitingNCT07744347
- A Phase Ⅲ Clinical Study of SNA02-48 InjectionNot yet recruitingNCT07633119Phase 3
- A First in Human Study Investigating the Safety of an Unloaded and Loaded (With a Tetanus-containing Vaccine Booster) Microneedle Patch in Healthy AdultsNot yet recruitingNCT07624669Phase 4
- Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months OldNot yet recruitingNCT07621341Phase 4
- Tetanus Severity Score for Prediction of Mortality in Manifest TetanusRecruitingNCT07512167
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)Not yet recruitingNCT07492303Phase 1
- TETANUS Antibody Detection in Saliva StudyNot yet recruitingNCT07446166Not applicable
- Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) VaccineNot yet recruitingNCT07418372Phase 1/2
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
- A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following InjuryRecruitingNCT07347938
- Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined VaccineRecruitingNCT07203755Phase 1
- Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody InjectionEnrolling by invitationNCT07149454Phase 1
- A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following InjuryRecruitingNCT07107932
- Study of Concomitant Administration of the sIPV and DTaP or MMRNot yet recruitingNCT06920069Phase 4
- Enhancing Maternal Vaccine Knowledge and Uptake: The InTroDuce-Programme TrialRecruitingNCT06815250Not applicable
- A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 InjectionRecruitingNCT06635798Phase 3
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination FormulationNot yet recruitingNCT06360250Early Phase 1
- Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined VaccineRecruitingNCT06184542Phase 1
- PFAS Exposure and Immune Response to Vaccination in AdultsCompletedNCT06588530Phase 4Results posted
- Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against TetanusCompletedNCT05664750Phase 3Results posted
- Safety and Immunogenicity Study of Tdap Vaccinations for Plasma DonorsCompletedNCT05662852Phase 2Results posted
- Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult VolunteersCompletedNCT05625477Phase 2Results posted
- Tdap Vaccine Safety for Plasma DonorsCompletedNCT04142983Phase 2/3Results posted
- Confirmatory Study of BK1310 in Healthy InfantsCompletedNCT03891758Phase 3Results posted
- Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their InfantsCompletedNCT03589768Phase 2Results posted
- Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian SubjectsCompletedNCT03311659Phase 3Results posted
- Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy InfantsCompletedNCT02907216Phase 4Results posted
- A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in RussiaCompletedNCT02858440Phase 3Results posted
- Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryCompletedNCT02853929Phase 4Results posted
- Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell TransplantationTerminatedNCT02700841Phase 2Results posted
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy SubjectsCompletedNCT02587520Phase 1/2Results posted
- Effect of Tetanus on Neuromuscular Junction Monitor Performance in Pediatric PatientsCompletedNCT02498678Not applicableResults posted
- Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryCompletedNCT02422264Phase 4Results posted
- Study of BK1301 (DTaP Vaccine) as a Booster in AdolescentsCompletedNCT02118961Phase 3Results posted
- Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years OldCompletedNCT02089347Phase 3Results posted
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at BirthCompletedNCT01948193Phase 3Results posted
- Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in ChinaCompletedNCT01933776Phase 1Results posted
- Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in KoreaCompletedNCT01929291Results posted
- Tdap Vaccine in Post-Partum WomenCompletedNCT01711645Phase 4Results posted
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in AdolescentsCompletedNCT01689324Phase 1/2Results posted
- Immunogenicity of Adacel® and BOOSTRIX® Vaccines in AdolescentsCompletedNCT01629589Phase 4Results posted
- Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese ToddlersCompletedNCT01577732Phase 3Results posted
- Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 YearsCompletedNCT01529645Phase 1Results posted
- Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy InfantsCompletedNCT01444781Phase 3Results posted
- Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous DoseCompletedNCT01439165Phase 4Results posted
- Regulatory Post-Marketing Surveillance Study for TETRAXIM™CompletedNCT01437423Phase 4Results posted
- Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type BCompletedNCT01362517Phase 3Results posted
- Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™CompletedNCT01358825Phase 4Results posted
- Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood VaccinationCompletedNCT01357720Phase 4Results posted
- Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) VaccineCompletedNCT01353703Phase 3Results posted
- Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of AgeCompletedNCT01346293Phase 3Results posted
- Study of Adacel® Vaccine Administered to Persons 10 Years of AgeCompletedNCT01311557Phase 4Results posted
- A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American InfantsCompletedNCT01177722Phase 3Results posted
- Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster DoseCompletedNCT01171989Phase 2Results posted
- Post Marketing Surveillance for ADACEL™ in South KoreaCompletedNCT01137435Phase 4Results posted
- A Study to Assess the Safety of Adacel® VaccineCompletedNCT01040052Phase 3Results posted
- Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of AgeCompletedNCT00970307Phase 2Results posted
- Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.CompletedNCT00835237Phase 3Results posted
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian InfantsCompletedNCT00831753Phase 3Results posted
- Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean InfantsCompletedNCT00831311Phase 2Results posted
- Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™CompletedNCT00802867Phase 4Results posted
- Immunogenicity and Safety of Adacel Polio VaccineCompletedNCT00797511Phase 3Results posted
- Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap VaccineCompletedNCT00777257Phase 4Results posted
- Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™CompletedNCT00772928Phase 3Results posted
- Retrospective Survey of Safety of Fourth Dose Pentacel® in ChildrenCompletedNCT00772369Results posted
- Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous DoseCompletedNCT00712959Phase 4Results posted
- Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™CompletedNCT00654901Phase 3Results posted
- Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio VaccineCompletedNCT00635128Phase 4Results posted
- Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.CompletedNCT00610168Phase 4Results posted
- Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured TdCompletedNCT00601835Phase 4Results posted
- Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058CompletedNCT00548171Phase 4Results posted
- Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™CompletedNCT00534833Phase 3Results posted
- A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In AdolescentsCompletedNCT00518180Phase 3Results posted
- Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino InfantsCompletedNCT00514709Phase 3Results posted
- Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/HibCompletedNCT00473668Phase 3Results posted
- Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of AgeCompletedNCT00467519Phase 3Results posted
- A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and OlderCompletedNCT00457249Phase 4Results posted
- Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy InfantsCompletedNCT00404651Phase 3Results posted
- Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®CompletedNCT00355121Phase 2Results posted
- Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy InfantsCompletedNCT00348881Phase 3Results posted
- Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® VaccineCompletedNCT00347958Phase 4Results posted
- Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 YearsCompletedNCT00346073Phase 3Results posted
- Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio VaccineCompletedNCT00343889Phase 3Results posted
- Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)CompletedNCT00337428Phase 3Results posted
- Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy InfantsCompletedNCT00325156Phase 4Results posted
- Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)CompletedNCT00325130Phase 3Results posted
- Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®CompletedNCT00319553Phase 4Results posted
- Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.CompletedNCT00313911Phase 3Results posted
- Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis VaccineCompletedNCT00304265Phase 4Results posted
- Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean InfantsCompletedNCT00303316Phase 3Results posted
- US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal DiseaseCompletedNCT00282295Phase 4Results posted
- Immunogenicity and Safety of ADACEL™ as Fifth Dose in TaiwanCompletedNCT00258908Phase 3Results posted
- Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®CompletedNCT00258895Phase 3Results posted
- Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in ChildrenCompletedNCT00228917Phase 3Results posted
- Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30mCompletedNCT00136604Phase 3Results posted
- Phase I/III Clinical Trial of Adsorbed Tetanus VaccineCompletedNCT07740733Phase 3